TrialStem cells and development2015

Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients.

Akihiko Taguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.